GTCR/Surmodics: FTC Staff Raises Concerns About Deal Creating Dominant Maker of Coatings for Medical Devices

GTCR’s attempted $627 million takeover of Surmodics (SRDX) could be in jeopardy as FTC staff raises concerns that the deal would transform the acquirer into the dominant maker of coatings for a number of medical devices, sources familiar with the matter said.

Published on Jan 28, 2025

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.